Using best-worst scaling in horizon scanning for hepatocellular carcinoma technologies

Published on Jul 1, 2012in International Journal of Technology Assessment in Health Care1.418
· DOI :10.1017/S026646231200027X
Gisselle Gallego16
Estimated H-index: 16
(Johns Hopkins University),
John F. P. Bridges29
Estimated H-index: 29
(Johns Hopkins University)
+ 2 AuthorsLouis W. Niessen31
Estimated H-index: 31
(Johns Hopkins University)
There is a growing need for efficient procedures for identification of emerging technologies by horizon scanning systems. We demonstrate the value of best-worst scaling (BWS) in exploring clinicians' views on emerging technologies that will impact outcomes in hepatocellular carcinoma (HCC) in the next 5 to 10 years.
  • References (22)
  • Citations (20)
📖 Papers frequently viewed together
75 Citations
132 Citations
434 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1John F. P. Bridges (Johns Hopkins University)H-Index: 29
#2Gisselle Gallego (Johns Hopkins University)H-Index: 16
Last. Barri M. Blauvelt (UMass: University of Massachusetts Amherst)H-Index: 7
view all 3 authors...
Background Liver cancer is the fifth most common cancer in men and the seventh for women. Usually because of late diagnosis, the prognosis for liver cancer remains poor, resulting in liver cancer being the third most common cause of death from cancer. While some countries have treatment guidelines, little is known or understood about the strategies needed for liver cancer control internationally.
10 CitationsSource
#1Joseph Torresi (University of Melbourne)H-Index: 39
#2Douglas F. Johnson (University of Melbourne)H-Index: 15
Last. Heiner WedemeyerH-Index: 73
view all 3 authors...
Hepatitis C virus (HCV) is a blood borne disease estimated to chronically infect 3% of the worlds' population causing significant morbidity and mortality. Current medical therapy is curative in approximately 50% of patients. While recent treatment advances of genotype 1 infection using directly acting antiviral agents (DAAs) are encouraging, there is still a need to develop vaccine strategies capable of preventing infection. Moreover, vaccines may also be used in future in combination with DAAs ...
109 CitationsSource
8 CitationsSource
#1Roselinde Kessels (University of Antwerp)H-Index: 12
#2Bradley Jones (SAS: SAS Institute)H-Index: 23
Last. Martina Vandebroek (Katholieke Universiteit Leuven)H-Index: 19
view all 4 authors...
Recently, the use of Bayesian optimal designs for discrete choice experiments, also called stated choice experiments or conjoint choice experiments, has gained much attention, stimulating the development of Bayesian choice design algorithms. Characteristic for the Bayesian design strategy is that it incorporates the available information about people's preferences for various product attributes in the choice design. This is in contrast with the linear design methodology, which is also used in di...
37 CitationsSource
#1Rosemary LordH-Index: 2
#2Abid Suddle (University of Cambridge)H-Index: 9
Last. Paul Ross (University of Cambridge)H-Index: 26
view all 3 authors...
Summary Hepatocellular cancer (HCC) is the fifth most common cause of cancer worldwide and its incidence is increasing as a result of the dissemination of hepatitis B and C virus infection. Surgical resection and liver transplantation are considered the only cures for HCC, but benefit approximately 10–15% of patients. In addition, radiofrequency ablation may is potentially curative for patients’ with small HCC. Some patients with unresectable disease confined to the liver may benefit from emboli...
18 CitationsSource
#1Boris Freidlin (NIH: National Institutes of Health)H-Index: 36
#2Edward L. KornH-Index: 51
Advancements made in molecularly targeted therapeutics have focussed increasing attention on biomarker-adaptive clinical trial designs as a means of improving the efficiency of drug development and advancing medical care. Here, we focus on randomized clinical trial (RCT) designs aimed at developing/validating clinically relevant pharmacogenomic biomarkers capable of identifying patients sensitive to a given therapy(s), and thereby, selecting the best therapy for a given patient. The term ‘biomar...
28 CitationsSource
#1Jordan J. Louviere (UTS: University of Technology, Sydney)H-Index: 83
#2Terry N. Flynn (UTS: University of Technology, Sydney)H-Index: 31
Background: One of the greatest difficulties in evaluating healthcare system reform in any country is that governments often do not clearly articulate what it is they are attempting to do. In Australia, a recent inquiry set out 15 principles to guide the reform process, but it remains unclear how the Australian public values the principles, how such values vary across the country, and, more fundamentally, if Australians understand the principles.
75 CitationsSource
#1Sheng Long Ye (Fudan University)H-Index: 10
#2Tadatoshi TakayamaH-Index: 68
Last. Jean Pierre BronowickiH-Index: 22
view all 5 authors...
For patients with early-stage hepatocellular carcinoma (HCC), potentially curative treatment options exist, including liver transplantation, surgical resection, and ablation therapy. These treatments are associated with survival benefits, and outcomes are optimized by identification of appropriate patients. However, further studies are needed to definitively confirm optimal treatment approaches for all patients. Treatment patterns vary in different parts of the world as a result of geographic di...
35 CitationsSource
#1Tania StafinskiH-Index: 20
#2Leigh-Ann TopferH-Index: 6
Last. Devidas MenonH-Index: 28
view all 4 authors...
Contexte: L'evaluation des technologies de la sante (ETS) est un outil qui doit aider les responsables des politiques a choisir les technologies a financer. Toutefois, etant donne la proliferation de technologies nouvelles, il est impossible de soumettre chacune d'entre elles a une ETS avant qu'elle soit financee. C'est pourquoi on a etabli des processus d'« analyse prospective » pour determiner les technologies emergentes susceptibles d'avoir un effet important sur la pratique clinique. Meme si...
13 Citations
Importance of the field: Hepatocellular cancer (HCC) is the fifth most common malignancy worldwide and third leading cause of cancer death. HCC is highly resistant to conventional systemic therapies, and prognosis for advanced HCC patients remains poor. However, identification of signaling pathways responsible for HCC growth and progression such as RAS/RAF/MEK/ERK or PI3K/AKT/mTOR has determined crucial molecular targets and led to development of novel promising targeted therapies.Areas covered ...
44 CitationsSource
Cited By20
#1Sarah A. Janse (OSU: Ohio State University)H-Index: 1
#2Sonya B. Dumanis (Epilepsy Foundation)H-Index: 1
Last. John Bridges (OSU: Ohio State University)H-Index: 3
view all 6 authors...
Abstract Background Epilepsy is the 4th most common neurological disorder and is characterized by recurrent, unpredictable seizures. The ability to forecast seizures is a significant unmet need and would have a transformative effect on the lives of people living with epilepsy. In an effort to address this need, the Epilepsy Foundation has committed effort and resources to promote the development of seizure forecasting devices (SFD). Objective To promote user-centered design of future SFD, we sou...
1 CitationsSource
#1Kei Long CheungH-Index: 6
#2Susanne Mayer (Medical University of Vienna)H-Index: 6
Last. Mickaël Hiligsmann (PHRI: Public Health Research Institute)H-Index: 28
view all 7 authors...
AbstractAims: Different methods have been used to analyze “object case” best–worst scaling (BWS). This study aims to compare the most common statistical analysis methods for object case BWS (i.e. the count analysis, multinomial logit, mixed logit, latent class analysis, and hierarchical Bayes estimation) and to analyze their potential advantages and limitations based on an applied example.Methods: Data were analyzed using the five analysis methods. Ranking results were compared among the methods...
1 CitationsSource
#1Rosangel CruzH-Index: 5
#2L. BelterH-Index: 1
Last. Jill JareckiH-Index: 7
view all 5 authors...
Abstract Purpose Patients’ perceptions of benefit–risk are essential to informing the regulatory process and the context in which potential therapies are evaluated. To bring this critical information to regulators, Cure SMA launched a first-ever Benefit-Risk Survey for spinal muscular atrophy (SMA) to characterize decision-making and benefit–risk trade-offs in SMA associated with a potential therapy. We hypothesized that risk tolerance would be correlated with SMA type/severity and disease progr...
#1Melissa C.W. Vaanholt (UT: University of Twente)H-Index: 1
#2Marlies M. Kok (Medisch Spectrum Twente)H-Index: 10
Last. Janine Astrid van Til (UT: University of Twente)H-Index: 15
view all 5 authors...
Objectives: To examine patients’ perspectives regarding composite endpoints and the utility patients put on possible adverse outcomes of revascularization procedures. Design: In the PRECORE study, a stated preference elicitation method Best-Worst Scaling (BWS) was used to determine patient preference for 8 component endpoints (CEs): need for redo percutaneous coronary intervention (PCI) within 1 year, minor stroke with symptoms <24 hours, minor myocardial infarction (MI) with symptoms <3 months,...
#1Ilene L. Hollin (Johns Hopkins University)H-Index: 10
#2Holly L. Peay (RTP: Research Triangle Park)H-Index: 15
Last. John F. P. Bridges (Johns Hopkins University)H-Index: 29
view all 4 authors...
Objective This study quantifies caregiver and patient preferences for a therapeutic agent with demonstrated pulmonary benefits for Duchenne muscular dystrophy (DMD). Caregivers and patient differences are also explored. Methods A best-worst scaling survey (BWS) was administered to caregivers and patients. Across 9 profiles, respondents selected the best and worst attributes. Utility scores were estimated using mixed logistic regression. Results Respondents indicated greatest preference for thera...
14 CitationsSource
#1Kei Long Cheung (UM: Maastricht University)H-Index: 6
#2Ben F. M. Wijnen (UM: Maastricht University)H-Index: 7
Last. Mickaël Hiligsmann (UM: Maastricht University)H-Index: 28
view all 7 authors...
Introduction Best–worst scaling (BWS) is becoming increasingly popular to elicit preferences in health care. However, little is known about current practice and trends in the use of BWS in health care. This study aimed to identify, review and critically appraise BWS in health care, and to identify trends over time in key aspects of BWS.
46 CitationsSource
#1Eve Wittenberg (Harvard University)H-Index: 21
#2Monica Bharel (Harvard University)H-Index: 12
Last. Linda Weinreb (UMMS: University of Massachusetts Medical School)H-Index: 20
view all 5 authors...
PURPOSE Best-worst scaling (BWS) is a survey method for assessing individuals' priorities. It identifies the extremes—best and worst items, most and least impor - tant factors, biggest and smallest influences—among sets. In this article, we demonstrate an application of BWS in a primary care setting to illustrate its use in identifying patient priorities for services. METHODS We conducted a BWS survey in 2014 in Boston, Massachusetts, to assess the relative importance of 10 previously identified...
7 CitationsSource
#1Holly L. Peay (LEI: Leiden University)H-Index: 15
#2Ilene L. Hollin (Johns Hopkins University)H-Index: 10
Last. John F. P. Bridges (Johns Hopkins University)H-Index: 29
view all 3 authors...
Duchenne muscular dystrophy (DMD) is a progressive, fatal pediatric disorder with significant burden on parents. Assessing disease impact can inform clinical interventions. Best-worst scaling (BWS) was used to elicit parental priorities among 16 short-term, DMD-related worries identified through community engagement. Respondents viewed 16 subsets of worries, identified using a balanced, incomplete block design, and identified the most and least worrying items. Priorities were assessed using best...
15 CitationsSource
#1Axel C. MühlbacherH-Index: 17
#2Anika KaczynskiH-Index: 5
Last. F. Reed Johnson (Duke University)H-Index: 36
view all 4 authors...
Best-worst scaling (BWS), also known as maximum-difference scaling, is a multiattribute approach to measuring preferences. BWS aims at the analysis of preferences regarding a set of attributes, their levels or alternatives. It is a stated-preference method based on the assumption that respondents are capable of making judgments regarding the best and the worst (or the most and least important, respectively) out of three or more elements of a choice-set. As is true of discrete choice experiments ...
28 CitationsSource
#1Chetna Malhotra (NUS: National University of Singapore)H-Index: 15
#2Noreen ChanH-Index: 3
Last. Eric A. Finkelstein (NUS: National University of Singapore)H-Index: 48
view all 5 authors...
Background There is high variability in end-of-life (EOL) treatments. Some of this could be due to differences in physician treatment recommendations, their knowledge/attitude regarding palliative care, and their perceived roles in treating patients with advanced serious illness (ASI). Thus, the objective of this paper was to identify potential variation in physician recommendations, their knowledge/attitude regarding palliative care and perceived roles in treating ASI patients.
7 CitationsSource